HRS

ANGI ENERGY SYSTEMS BREAKS NEW GROUND BY STARTING CONSTRUCTION OF THE MIDWEST'S FIRST HYDROGEN REFUELING TEST FACILITY

Retrieved on: 
Friday, March 22, 2024

JANESVILLE, Wis., March 22, 2024 /PRNewswire/ -- ANGI Energy Systems, a Vontier (NYSE: VNT) business, yesterday broke ground on its new, $4 million Hydrogen Refueling Test Facility: the first of its kind in the Midwest. Attending today were senior executives from ANGI and FASTECH, together with members of the Janesville and wider Wisconsin administration and community.

Key Points: 
  • Attending today were senior executives from ANGI and FASTECH, together with members of the Janesville and wider Wisconsin administration and community.
  • Building on its strategic vision to provide an end-to-end, multi-energy refueling platform for the fleet and heavy-duty transportation sector, ANGI has experienced remarkable growth in the last three years.
  • To support continued, strategic expansion, the new facility will be a cornerstone for R&D activity and will play a pivotal role in the testing, and validation of hydrogen refueling station systems and components – including functional testing of globally standardized SAE J2601 refueling protocols for gaseous hydrogen.
  • ANGI is also preparing to ship and build its first Hydrogen Refueling Station (HRS) customer order from Trillium Energy to be installed at Santa Clarita Transit this Summer.

ANGI ENERGY SYSTEMS BREAKS NEW GROUND BY STARTING CONSTRUCTION OF THE MIDWEST'S FIRST HYDROGEN REFUELING TEST FACILITY

Retrieved on: 
Friday, March 22, 2024

JANESVILLE, Wis. , March 22, 2024 /PRNewswire/ -- ANGI Energy Systems, a Vontier (NYSE: VNT) business, yesterday broke ground on its new, $4 million Hydrogen Refueling Test Facility: the first of its kind in the Midwest. Attending today were senior executives from ANGI and FASTECH, together with members of the Janesville and wider Wisconsin administration and community.

Key Points: 
  • Attending today were senior executives from ANGI and FASTECH, together with members of the Janesville and wider Wisconsin administration and community.
  • Building on its strategic vision to provide an end-to-end, multi-energy refueling platform for the fleet and heavy-duty transportation sector, ANGI has experienced remarkable growth in the last three years.
  • To support continued, strategic expansion, the new facility will be a cornerstone for R&D activity and will play a pivotal role in the testing, and validation of hydrogen refueling station systems and components – including functional testing of globally standardized SAE J2601 refueling protocols for gaseous hydrogen.
  • ANGI is also preparing to ship and build its first Hydrogen Refueling Station (HRS) customer order from Trillium Energy to be installed at Santa Clarita Transit this Summer.

Celly and Cyclum Renewable Truck Stops Announce Initial Agreement to Revolutionize Truck Stop Hydrogen Infrastructure

Retrieved on: 
Monday, March 11, 2024

HOUSTON, March 11, 2024 /PRNewswire-PRWeb/ -- Revolutionizing the energy industry with green Hydrogen, Celly is a dynamic business driving change. Based in Texas, Celly H2 LLC stands poised to redefine industry norms as a leading distributor of green hydrogen fuel. With a steadfast dedication to delivering clean, reliable, and cost-effective energy alternatives, Celly emerges as the ideal ally for Cyclum and others seeking sustainable energy solutions. Their comprehensive services span from delivering and dispensing low CI hydrogen to cutting-edge modular refueling stations, encompassing operations, maintenance, and logistics, placing Celly at the vanguard of a greener tomorrow. Inspired by successful models in Europe, Celly is committed to sustainability and efficiency, offering hydrogen fuels tailored for municipalities, transit authorities, fleet owners, industrial users, refineries, ports, and businesses alike. Embracing an innovative "drop and swap" approach to hydrogen transport, Celly epitomizes the future of sustainable energy distribution.

Key Points: 
  • Celly and Cyclum have forged a groundbreaking partnership aimed at revolutionizing truck stop infrastructure and advancing sustainable energy solutions.
  • Leveraging Celly's expertise in green hydrogen distribution and Cyclum's innovative approach to truck stop design, the partnership seeks to integrate state-of-the-art Celly Hydrogen Refueling Stations (HRS) at Cyclum Truck Stop locations across California and Florida.
  • This next level in the Truck Stop Industry aligns perfectly with Celly's expertise in designing and implementing Hydrogen sustainable solutions.
  • In collaboration, Cyclum and Celly are excited to join forces and pioneer the future of truck stop infrastructure.

Excella Awarded Data Science and Analytics BPA and Initial Call Orders for U.S. Office of Personnel Management

Retrieved on: 
Monday, March 4, 2024

Excella, a pioneer in Agile technology solutions, today announced that the company has been awarded the U.S. Office of Personnel Management (OPM) Data Science and Analytics Support Services (DSASS) Blanket Purchase Agreement as well as the first two Call Orders issued under the contract.

Key Points: 
  • Excella, a pioneer in Agile technology solutions, today announced that the company has been awarded the U.S. Office of Personnel Management (OPM) Data Science and Analytics Support Services (DSASS) Blanket Purchase Agreement as well as the first two Call Orders issued under the contract.
  • Work under this contract will support the Human Resources Solutions (HRS) Federal Staffing Center (FSC), HRS Information Technology Program Management Office (HRS-ITPMO), Human Capital Data Management and Modernization (HCDMM), and other OPM data programs.
  • The team will draw on nearly 20 years of working with OPM developing a range of solutions and programs that share actionable data.
  • Excella also supports the development of data and analytics tools to detect fraud, analyze risk, and manage contracts and grants in agencies across the federal government.

PrepMD Partners with MediaSphere and Esteemed Cardiac Experts for Groundbreaking Virtual Device Clinic Leadership Summit

Retrieved on: 
Wednesday, February 21, 2024

BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.

Key Points: 
  • BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.
  • The summit aims to gather leading experts in cardiac device clinic management for a deep dive into pivotal topics.
  • The summit is privileged to feature a panel of esteemed faculty members, each recognized for their significant contributions to cardiac care:
    Beth Davenport, MSN, RN, Clinical Translation Specialist at Biotronik (Former Director of Virtual Care and Cardiac Device Clinic, Sanger Heart & Vascular ), Charlotte, NC
    Sallie Gustafson, RN, Manager of Device Clinic at Emory Clinic, Emory Healthcare , Atlanta, GA
    Nancy Lee, RN, FHRS, CCDS, Regional Director of Device Operations, Clinical Arrhythmia Device Nurse, Prairie Cardiovascular Consultants, Ltd. , O'Fallon, IL
    Amy Tucker, MSN, RN, CCDS, Nurse Manager, Cardiac Device Clinic, Sanger Heart & Vascular Institute , Charlotte, NC
    The Device Clinic Summit is an essential event for all involved in cardiac device clinic management, offering a crucial forum for improving practices and patient care.
  • For registration and additional details, please visit the official website of the summit , hosted by The Journal of Innovations in Cardiac Rhythm Management™.

Reverse Hip Replacement System Unveiled at Global Orthopedic Surgery Meeting

Retrieved on: 
Thursday, February 15, 2024

SAN FRANCISCO, Feb. 15, 2024 /PRNewswire/ -- Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care for patients, today announced that its flagship product, the Reverse Hip Replacement System (Reverse HRS) was showcased at the 2024 American Academy of Orthopaedic Surgeons (AAOS) annual meeting, taking place in San Francisco, CA from February 12 -16, 2024.

Key Points: 
  • "We are extremely excited that the Reverse HRS was featured at AAOS in the OrthoDome with a video of an actual hip replacement surgery narrated by Dr. Adolph Lombardi," said George Diamantoni, Hip Innovation Technology's Co-Founder and Chief Executive Officer.
  • The presentation featured high resolution video of Dr. Lombardi conducting a hip replacement with the new Reverse HRS.
  • The Bone & Joint Open journal, recently published the article, "Radiostereometric analysis and clinical outcomes of a novel reverse total hip system at two years."
  • Hip replacement surgery, or total hip arthroplasty, is one of the most common joint replacement procedures done in the United States.

ParagonX Holdings, Inc. Transformational Plan Update

Retrieved on: 
Thursday, February 15, 2024

The company announced that its subsidiary HRS has secured $18 Million in new contracts contingent upon closing on additional capital.

Key Points: 
  • The company announced that its subsidiary HRS has secured $18 Million in new contracts contingent upon closing on additional capital.
  • The company reduced its debt by over $5 million since August 2023.
  • The company is preparing for a Shareholder vote to elect additional directors and to replace Bob Cornaglia who resigned this week.
  • The company will call for a Shareholder vote, if required, to effectuate the acquisitions currently being evaluated by Caprino Management.

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

Retrieved on: 
Monday, January 22, 2024

DUBLIN, Jan. 22, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of findings from a post hoc analysis of the Phase 3 CONFIRM clinical trial. In this analysis, treatment with TERLIVAZ® (terlipressin) for injection was associated with improvements in verified hepatorenal syndrome (HRS) reversal and HRS reversal vs. placebo in adult cirrhosis patients with alcoholic hepatitis (AH) and HRS with rapid reduction in kidney function.1,2 The results will be shared in an oral presentation at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress, taking place January 21-23, 2024, in Phoenix, AZ.

Key Points: 
  • Patients with volume overload or with acute-on-chronic liver failure (ACLF) Grade 3 are at increased risk.
  • Monitor patients for hypoxia using continuous pulse oximetry during treatment and discontinue TERLIVAZ if SpO2 decreases below 90%.
  • Ineligibility for Liver Transplant: TERLIVAZ-related adverse reactions (respiratory failure, ischemia) may make a patient ineligible for liver transplantation, if listed.
  • For patients with high prioritization for liver transplantation (e.g., MELD ≥35), the benefits of TERLIVAZ may not outweigh its risks.

Health Recovery Solutions (HRS) Applauded by Frost & Sullivan for Transforming Remote Care Delivery with Its Clinically Enabled, Patient-centric RPM Solutions

Retrieved on: 
Tuesday, January 9, 2024

SAN ANTONIO, Jan. 9, 2024 /PRNewswire/ -- Frost & Sullivan researched the remote patient monitoring (RPM) industry and, based on its analysis, recognizes Health Recovery Solutions with the 2023 North American Customer Value Leadership Award. The healthcare technology company provides Enterprise acute and post acute, and ambulatory RPM services to payors, hospitals, and health systems. HRS improves care coordination and reduces total cost of care for the largest insurers nationally such as UHC/Optum and BCBS, improving patient outcomes and driving revenue growth. Actively monitoring more than 450,000 lives across the care continuum and serving over 320 clients in the United States and Canada, the company has established itself as a trusted partner that delivers value to the nation's foremost healthcare providers. HRS' comprehensive offering enables clients to prioritize patient care by managing all administrative and technology related RPM responsibilities.

Key Points: 
  • SAN ANTONIO, Jan. 9, 2024 /PRNewswire/ -- Frost & Sullivan researched the remote patient monitoring (RPM) industry and, based on its analysis, recognizes Health Recovery Solutions with the 2023 North American Customer Value Leadership Award.
  • The healthcare technology company provides Enterprise acute and post acute, and ambulatory RPM services to payors, hospitals, and health systems.
  • HRS' comprehensive offering enables clients to prioritize patient care by managing all administrative and technology related RPM responsibilities.
  • Clinical and non-clinical tele-monitoring services provide telehealth tools to streamline managed care, incorporating CareConnect, CaregiverConnect, WoundConnect, and PatientConnect® RPM.

Health Recovery Solutions (HRS) Applauded by Frost & Sullivan for Transforming Remote Care Delivery with Its Clinically Enabled, Patient-centric RPM Solutions

Retrieved on: 
Tuesday, January 9, 2024

SAN ANTONIO, Jan. 9, 2024 /PRNewswire/ -- Frost & Sullivan researched the remote patient monitoring (RPM) industry and, based on its analysis, recognizes Health Recovery Solutions with the 2023 North American Customer Value Leadership Award. The healthcare technology company provides Enterprise acute and post acute, and ambulatory RPM services to payors, hospitals, and health systems. HRS improves care coordination and reduces total cost of care for the largest insurers nationally such as UHC/Optum and BCBS, improving patient outcomes and driving revenue growth. Actively monitoring more than 450,000 lives across the care continuum and serving over 320 clients in the United States and Canada, the company has established itself as a trusted partner that delivers value to the nation's foremost healthcare providers. HRS' comprehensive offering enables clients to prioritize patient care by managing all administrative and technology related RPM responsibilities.

Key Points: 
  • SAN ANTONIO, Jan. 9, 2024 /PRNewswire/ -- Frost & Sullivan researched the remote patient monitoring (RPM) industry and, based on its analysis, recognizes Health Recovery Solutions with the 2023 North American Customer Value Leadership Award.
  • The healthcare technology company provides Enterprise acute and post acute, and ambulatory RPM services to payors, hospitals, and health systems.
  • HRS' comprehensive offering enables clients to prioritize patient care by managing all administrative and technology related RPM responsibilities.
  • Clinical and non-clinical tele-monitoring services provide telehealth tools to streamline managed care, incorporating CareConnect, CaregiverConnect, WoundConnect, and PatientConnect® RPM.